European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Covalently closed DNA plasmids coding for cytomegalovirus
Community Register of medicinal products
Community register of orphan medicinal products | GRANTED |
Product information |
Covalently closed DNA plasmids coding for cytomegalovirus phosphoprotein 65 and glycoprotein B genes
| EU orphan designation number: | EU/3/12/1042
|
| Active ingredient: | Covalently closed DNA plasmids coding for cytomegalovirus phosphoprotein 65 and glycoprotein B genes |
| Indication: | Prevention of cytomegalovirus disease in patients with impaired cell mediated immunity deemed at risk |
| Sponsor: | Astellas Pharma Europe B.V.
Sylviusweg 62, NL-2333 BE Leiden, Nederland |
Public summary of scientific opinion
European Commission procedures
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 13/08/2012 | Centralised Orphan - Designation | EMA/OD/003/12 | (2012)5805 of 09/08/2012 | |||
| 05/02/2013 | Other procedure |